CD4 and AIDS: Conclusions: Under our strong assumptions, our analysis suggests that in ART‐naïve PWH with CD4 count <200 or AIDS initiating ART with DTG versus DRV/b‐based regimens leads to a 50% reduction in the risk of treatment failure.